Divya Anthwal
Overview
Explore the profile of Divya Anthwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma P, Gupta R, Aittan S, Anthwal D, Dass M, Yadav R, et al.
Nanotheranostics
. 2025 Jan;
9(1):20-30.
PMID: 39744100
Pleural tuberculosis (pTB) is a diagnostic challenge because of its non-specific clinical features, lack of accurate diagnostic tools and paucibacillary nature of the disease. We, here describe the development of...
2.
Jindal N, Sharma P, Punia S, Dass M, Anthwal D, Gupta R, et al.
Tuberculosis (Edinb)
. 2024 Dec;
150:102578.
PMID: 39647431
Extracellular vesicles (EVs) have recently emerged as a source of microbe-specific biomarkers for disease diagnosis. In the present study, we evaluated the utility of pleural fluid-derived extracellular vesicles (pEVs) as...
3.
Chauhan K, Gupta R, Anthwal D, Panwalkar N, Desikan P, Bhalla M, et al.
Infect Dis (Lond)
. 2024 Aug;
56(12):1040-1048.
PMID: 39150281
Background: India relies primarily on direct smear microscopy for tuberculosis (TB) diagnosis. However, the low sensitivity of smear microscopy emphasizes the need to improve its performance. We recently described the...
4.
Gupta R, Anthwal D, Bhalla M, Sivaswami Tyagi J, Choudhary S, Haldar S
Curr Microbiol
. 2023 Dec;
81(1):27.
PMID: 38041739
Multidrug-resistant tuberculosis (MDR-TB) requires treatment with fluoroquinolone (FLQ) drugs, however, the excessive use of FLQ has led to the rise of extensively drug-resistant TB. In 2019, ~ 20% of total...
5.
Sharma P, Gupta R, Anthwal D, Dass M, Yadav R, Behera A, et al.
Tuberculosis (Edinb)
. 2023 Aug;
142:102369.
PMID: 37536090
Pleural tuberculosis (pTB) is a grave clinical challenge. A novel cell-free M. tuberculosis DNA (cfM.tb-DNA) probe-based-qPCR assay was developed for the diagnosis of pTB. Total cell-free DNA was extracted from...
6.
Dass M, Kaur M, Aittan S, Sharma P, Punia S, Muthumohan R, et al.
Diagn Microbiol Infect Dis
. 2023 Jun;
107(1):115973.
PMID: 37348159
In view of WHO's "End-TB" strategy, we developed a non-invasive, urine-based ELISA, targeting 2 Mycobacterium tuberculosis antigens namely MPT51 and MPT64 for extrapulmonary TB (EPTB) diagnosis. Suspected EPTB patients (n ...
7.
Dass M, Aittan S, Muthumohan R, Anthwal D, Gupta R, Mahajan G, et al.
Tuberculosis (Edinb)
. 2022 Jun;
135:102213.
PMID: 35696959
Tuberculous Meningitis (TBM) diagnosis remains a grave challenge. We evaluated the utility of extracellular vesicles (EVs) as a source of cell-free transrenal-mycobacterial DNA (cf-Tr-MTB DNA) for TBM diagnosis from urine...
8.
Kumari P, Dhiman A, Lavania S, Sharma P, Rath D, Anthwal D, et al.
Tuberculosis (Edinb)
. 2022 Apr;
134:102206.
PMID: 35462326
The diagnosis of abdominal tuberculosis (aTB) is challenging and there is an urgent need for an accurate diagnostic test. We have developed a high affinity DNA aptamer against GlcB antigen...
9.
Anthwal D, Jamwal S, Gupta R, Singhal R, Verma A, Bhalla M, et al.
Curr Microbiol
. 2022 Feb;
79(4):110.
PMID: 35175411
In 2019, amongst half a million new rifampicin-resistant tuberculosis (TB) cases, 78% were multi drug-resistant TB (MDR-TB). Access to rapid and Universal-Drug susceptibility testing (DST) to patients in remote areas...
10.
Anthwal D, Gupta R, Singhal R, Bhalla M, Verma A, Umar Khayyam K, et al.
ERJ Open Res
. 2021 Aug;
7(3).
PMID: 34350282
Background: Near-patient access to appropriate tests is a major obstacle for the efficient diagnosis of tuberculosis (TB) and associated drug resistance. Methods: We recently developed the "TB Concentration & Transport"...